University of Washington Addictions, Drug, and Alcohol Institute
(UW ADAI)

A keynote speaker went over trends in cannabis consumption related to high potency products, aiming to dispel the argument that product prohibitions undermine public health goals.

UW ADAI leaders opened the day-long event by claiming revised regulation of cannabis concentrates would establish the state as a wise “big brother” learning from legalization.

It could be a controversial week for cannabis policy in Washington state given debates around social equity rules and research concerns about “High THC Cannabis Products.”

Panelists with experience in drug prevention and behavioral science couldn’t reach consensus on the question of what makes cannabinoids impairing during a final dialogue on the topic.

In addition to a full slate of WSLCB public meetings, the agency planned to host a final deliberative dialogue and the social equity task force production work group would meet.

An outline of the education approach of the Enforcement and Education division was provided to the board, in addition to rulemaking updates and information on upcoming agency events.

The Governor shared his thoughts on the supplemental budget before signing it; the measure created two hemp task forces, a community reinvestment fund, and other cannabis-centric changes.

The Governor signed a bill which changed non-binding cannabis revenue appropriations and mandated a study of those expenditures by the Joint Legislative Audit and Review Committee.

Legislative leaders of cannabis policy committees talked about a few successes in 2022, and the more numerous failures around medical cannabis, equity, and cannabinoid regulation bills.

Staff briefed on a bill with complex changes to recommended cannabis tax appropriations before testimony emphasized benefits for transparency, social equity, and local governments.